Alkem Laboratories

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue2,8002,6192,4842,5763,079
Expenses2,2482,1982,2302,4492,703
EBITDA551.55420.99254.09126.98376.51
EBIT478.72343.53170.9550.72299.11
Profit Before Tax581.54463.94242.68151.89402.33
Net Profit544.26525.66107.58127.64330.84
Financial Ratios
Operating Profit Margin19.70%16.07%10.23%4.93%12.23%
Net Profit Margin19.44%20.07%4.33%4.95%10.74%
Earning Per Share (Diluted)45.5243.969.0010.6827.67
Dividends Per Share30.00NA4.00NANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI